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Editorial
Recent advances in lipid droplet biology
Since antiquity, the presence of excess adipose tissue has been identified as a cause of poor health and diminished longevity. Hippocrates wrote,
“It is very injurious to health to take in more food than the constitution will bear, when, at the same time one uses no exercise to carry off this excess”
[1]. Although similar ideas recorded through the centuries continued to expose the health hazards of obesity [2], our current understanding of why
excess fat accumulation is injurious has required multiple technical advances. These include the ability to separate different forms of lipids, the
development of histological techniques, the recognition that triacylglycerol (TAG) accumulation is associated with insulin resistance and the me-
tabolic syndrome, the identification of enzymes of TAG synthesis and degradation, and finally, the realization that lipid droplets (LDs) are not just
accumulations of inert lipid, but are, in fact, functional cellular organelles.
LDs were first noticed in cells in the 1880s when “lifeless food-matter” was described in egg yolk and egg cytosol as “fat-drops”, “oil-drops,” or “fatty
deutoplasm-spheres” [3] and in frog fatty liver [4]. After these initial histological descriptions, LDs were noted in a variety of tissues, including the adrenal
gland in which they were believed to represent a “glandular product” [5]. In the 1950s and 60s, when intracellular structures could be visualized by electron
microscopy, conflicting views arose as to the origin of LDs, including their possible derivation from microbodies that were also the source of mitochondria
[6,7] or their development in intracisternal spaces of the endoplasmic reticulum [8]. LDs were notable in regenerating liver after partial hepatectomy [9],
where they were thought to be taken up by pinocytosis and perhaps then oxidized, since they seemed to associate with mitochondria [10]. Pinocytosis of
tiny, unobservable LDs was also believed to occur in intestinal epithelial cells after a fatty meal [11]. It was recognized that the origin of LDs differed from
that of lipoprotein particles because when isolated perfused livers were incubated with puromycin to block protein synthesis, only the production of lipid
within the secretory apparatus was inhibited [12]. The fate of LDs was also a matter of contention. For example, it was considered likely that after cream
feeding, tiny lipid droplets might enter intestinal mucosal cells, coalesce, and then reach the Golgi complex intact for secretion into the lymph [11,13].
Meanwhile, biochemical studies determined the location of TAG synthesis. Autoradiography after injections of tritiated glucose indicated that TAG was
synthesized in the endoplasmic reticulum of intestinal epithelial cells [14] and liver [8]. The endoplasmic reticulum location was confirmed by showing
that, apart from phosphatidic phosphohydrolase, all the enzymes of TAG and phospholipid synthesis were present in liver microsomal fractions [15].
In spite of the fact that they were present in virtually every cell, little attention was paid to the LDs themselves, apart from recognition that their
fatty acid content was a cellular source of energy and contributed to the synthesis of the TAG that was secreted in lipoproteins and milk. The origin of
LDs was of little interest until the discovery in 1991 of the first droplet-specific protein, the heavily phosphorylated perilipin 1 (PLIN1) [16]. Since
then, interest in LDs has grown dramatically because of their relationship to insulin resistance, their use as fuels, their use in specialized programs of
autophagy and exosome production, their function as organizational centers or scaffolds for the construction of virus particles, and their ability to
release signaling molecules and transcription factor ligands. Hoping to present some of the newest and most interesting areas in lipid droplet
research, we invited speakers from the 2016 FASEB Summer Conference on Lipid Droplets: Dynamic Organelles in Metabolism and Beyond to place
their novel findings in a more general context and to identify critical areas that require additional attention.
Numerous synthetic and lipolytic enzymes are required to store or degrade neutral lipids. Karen Reue and her colleagues review the three lipin/
phosphatidic phosphohydrolases that convert phosphatidic acid (PA) to diacylglycerol to regulate the synthesis of TAG and the major phospholipids.
Jun Liu and his colleagues update information on G0S2, which is a major regulator of ATGL, the primary LD TAG lipase. Focusing on sphingolipid
metabolism, Mariana Nikolova-Karakashian and Gergana Deevska provide a comprehensive overview of the role of sphingolipids in LD biogenesis.
Interest in the cell biology of LDs is growing, particularly their roles in autophagy, as discussed by Kirill Bersuker and James Olzmann, and in
lipophagy, discussed by Douglas Mashek and his colleagues. Maya Schuldiner and Maria Bohnert provide new insights on the emerging concept that
LDs dynamically form and dissolve contact sites with other organelles, Peng Li and her colleagues focus on Cidec and its role in LD fusion, and Xiao
Chen and Joel Goodman discuss the contributions of seipin, perilipin, and the Fit proteins in LD assembly.
Proteomics studies have identified a multitude of specific LD proteins, and we asked Sander Kersten and Monserrat de la Rosa Rodriquez to
discuss the regulation of several of these proteins by PPARα, PPARδ, and PPARγ in adipose tissue, liver, macrophages and skeletal muscle. Dawn
Brasaemle and Carole Sztalryd focus on the PLIN proteins, and Mark Brown and Amanda Brown bring us up to date on CGI-58 and its roles in
lipolysis and energy homeostasis.
LDs perform several specialized roles in cells. Matthijs Hesselink and Bret Goodpaster explore the role of LDs and related parameters that affect
the insulin sensitivity of human muscle cells as well as novel imaging based tools to study these parameters. Matt Watt and Yunsheng Cheng focus on
the metabolism of muscle neutral lipids during exercise. Michael Welte and Alex Gould discuss functions of LDs that do not involve energy storage,
and Hongyuan Robert Yang examines the problem of seipin-related lipodystrophy and the role of phosphatidic acid in forming huge lipid droplets.
Because LD metabolism in non-mammalian organisms is of considerable interest, we are sorry to have had to omit important recent studies on
plant LDs [17,18]. We also regret that we have not been able to include all the exciting developments in the LD field, but wish to highlight recent
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excellent reviews on specialized topics, including lipid degradation [19], LDs and liver disease [20], the roles of major phospholipids [21], LD
diversity [22], and the requirement for LDs by replicating intracellular pathogens [23].
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